Big Pharma keeps raking in record profits while everyday Americans struggle with sky-high drug prices. These greedy corporations made over $800 billion last year, with profit margins ten times higher than other parts of the healthcare system. It’s clear who’s really getting rich off sick patients – and it’s not your local pharmacist.
Merck sits atop the Pharma throne, pulling in $64 billion last year mainly from its cancer drug Keytruda. That one drug alone brought in $29.5 billion – enough money to buy a new pickup truck for every family in Texas. Meanwhile, Pfizer still clings to second place despite its COVID cash cow drying up. Their stock crash shows what happens when companies put all their eggs in the government handout basket.
These companies cry poverty while charging $1,000 per pill. A new study proves Big Pharma’s profit margins average 23% – compared to just 2% for drugstores and distributors. They’re not just making money – they’re vacuuming up entire hospital budgets through price-gouging and patent tricks. This isn’t innovation – it’s highway robbery with a lab coat.
While Americans foot the bill, Europe and China pay pennies for the same medicines. US patients essentially fund global drug research through our nosebleed prices. It’s time NATO countries put their money where their medicine cabinets are. Why should US taxpayers bankroll Germany’s cheap drugs?
Big Pharma’s tentacles reach deep into Washington and the media. They spend billions lobbying politicians and buying positive press. No wonder Congress never fixes this broken system – half of them are on Pharma’s payroll. These companies don’t just sell pills – they peddle influence like street-corner hustlers.
The pandemic proved Pharma’s priorities. They got rich quick selling vaccines while Main Street businesses died. Now they’re scrambling to replace COVID cash with new blockbuster drugs. Their stock prices swing like a pendulum – stable only when taxpayers bail them out.
Real healthcare reform starts with busting Pharma’s patent monopolies and making other countries pay fair prices. Let’s stop being the world’s pharmacy piggybank. Drug innovation matters – but not when it’s built on the backs of broke cancer patients.
Hardworking Americans deserve better than being treated like walking ATMs for billionaire executives. It’s time to put America First – force these globalist corporations to lower prices here before shipping cheap drugs overseas. The cure for Pharma greed isn’t more regulation – it’s holding them accountable to the people who actually pay their bills.
